Revenue Recognition and Accounts Receivable - Schedule of Net Sales by Product Category by Reporting Segment (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Revenue Recognition And Accounts Receivable [Line Items]
Net sales	$ 193,646	$ 188,608
Change	2.70%
Bone Growth Therapies [Member]
Revenue Recognition And Accounts Receivable [Line Items]
Net sales	$ 55,050	52,477
Change	4.90%
Spinal Implants, Biologics, and Enabling Technologies [Member]
Revenue Recognition And Accounts Receivable [Line Items]
Net sales	$ 108,786	108,816
Change	0.00%
Global Spine [Member]
Revenue Recognition And Accounts Receivable [Line Items]
Net sales	$ 163,836	161,293
Change	1.60%
Global Orthopedics [Member]
Revenue Recognition And Accounts Receivable [Line Items]
Net sales	$ 29,810	$ 27,315
Change	9.10%